Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia

NCT00962390 is registered in ClinicalTrials.gov with Ausio Pharmaceuticals, LLC as lead sponsor.

NCT NCT00962390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00962390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Lead sponsor
Ausio Pharmaceuticals, LLC
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2009
Completion date
January 31, 2016
Enrollment
116 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia